[
  {
    "ts": null,
    "headline": "1 Healthcare Stock Primed for Growth and 2 to Avoid",
    "summary": "Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps have persisted in the wake of COVID-19 as players destocked inventories in 2023 and 2024. This has weighed on the returns lately as the industry has pulled back by 1.7% over the past six months, a noticeable divergence from the S&P 500’s 9% return.",
    "url": "https://finnhub.io/api/news?id=1f05f43afe55515160a0426ea3089c8374d87a010210e866e0ecc1eb6dd3c6be",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739797976,
      "headline": "1 Healthcare Stock Primed for Growth and 2 to Avoid",
      "id": 133190951,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "STE",
      "source": "Yahoo",
      "summary": "Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps have persisted in the wake of COVID-19 as players destocked inventories in 2023 and 2024. This has weighed on the returns lately as the industry has pulled back by 1.7% over the past six months, a noticeable divergence from the S&P 500’s 9% return.",
      "url": "https://finnhub.io/api/news?id=1f05f43afe55515160a0426ea3089c8374d87a010210e866e0ecc1eb6dd3c6be"
    }
  },
  {
    "ts": null,
    "headline": "1 Healthcare Stock Primed for Growth and 2 to Snub",
    "summary": "Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the industry’s returns - over the past six months, healthcare stocks have collectively shed 1.7%. This drop is a stark contrast from the S&P 500’s 9% gain.",
    "url": "https://finnhub.io/api/news?id=d60708befd2ae709703331335e10d16311c2984c83cda2a5ce382241cc024a10",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739795676,
      "headline": "1 Healthcare Stock Primed for Growth and 2 to Snub",
      "id": 133190952,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "STE",
      "source": "Yahoo",
      "summary": "Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the industry’s returns - over the past six months, healthcare stocks have collectively shed 1.7%. This drop is a stark contrast from the S&P 500’s 9% gain.",
      "url": "https://finnhub.io/api/news?id=d60708befd2ae709703331335e10d16311c2984c83cda2a5ce382241cc024a10"
    }
  }
]